Prescribing a walk: can simple exercise boost life quality for blood cancer patients?
NCT ID NCT06299540
Summary
This study is testing if a personalized physical activity program can improve the day-to-day well-being of people with chronic lymphocytic leukemia (CLL) who are starting a medication called ibrutinib. It will involve 180 participants who will follow an exercise plan and track their activity and sleep with a smartwatch. The main goal is to see if this program helps patients feel better physically and emotionally while on treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institut Universitaire du Cancer Toulouse Oncopole
RECRUITINGToulouse, 31059, France
Conditions
Explore the condition pages connected to this study.